New Cholesterol Numbers Your Doctor Needs to Check

New 2026 cardiology guidelines highlight three additional cholesterol markers crucial for assessing heart disease risk beyond just LDL. These include non-HDL cholesterol, which captures a wider range of harmful particles, particularly beneficial for individuals with diabetes or obesity. ApoB testing is also emphasized, as it quantifies the actual number of harmful cholesterol-carrying particles circulating in the blood, offering insights even when LDL levels appear normal.

The guideline also draws attention to Lp(a), a largely inherited marker that is unaffected by statins, diet, or exercise. Approximately one in five individuals worldwide have elevated Lp(a) levels. South Asian populations show a higher prevalence, with about 25% affected, often experiencing earlier onset of coronary artery disease. The new guidelines recommend checking Lp(a) at least once in every adult's life.

Dr. Nickhil Jakatdar advises that while non-HDL is often automatically calculated, ApoB and Lp(a) typically require specific requests. This underscores the growing importance of personalized preventive care platforms that integrate genetic, drug response, and blood test data for a comprehensive health assessment.